Howe & Rusling Inc Biomarin Pharmaceutical Inc Transaction History

Howe & Rusling Inc

$1.16 Billion
Q4 2024

A detailed history of Howe & Rusling Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Howe & Rusling Inc holds 39,355 shares of BMRN stock, worth $2.18 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

39,355

Previous 49,652 20.74%

Holding current value

$2.18 Million

Previous $3.49 Million 25.9%

% of portfolio

0.22%

Previous 0.3%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$61.93 - $70.49 $637,693 - $725,835	-10,297 Reduced 20.74%	39,355 $2.59 Million
Q3 2024 Nov 08, 2024	BUY	$69.02 - $93.84 $1.72 Million - $2.34 Million	24,971 Added 101.17%	49,652 $3.49 Million
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $15,928 - $19,735	214 Added 0.87%	24,681 $2.03 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $13,744 - $16,236	-164 Reduced 0.67%	24,467 $2.14 Million
Q4 2023 Feb 05, 2024	BUY	$76.22 - $98.51 $2,362 - $3,053	31 Added 0.13%	24,631 $2.37 Million
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $936,875 - $1.04 Million	-11,013 Reduced 30.92%	24,600 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $6,414 - $7,422	-74 Reduced 0.21%	35,613 $3.09 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $51,942 - $69,423	-592 Reduced 1.63%	35,687 $3.47 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $10,359 - $13,904	128 Added 0.35%	36,279 $3.75 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $35,739 - $42,168	435 Added 1.22%	36,151 $3.07 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $7,934 - $9,640	111 Added 0.31%	35,716 $2.96 Million
Q1 2022 May 10, 2022	BUY	$74.28 - $92.69 $762,261 - $951,184	10,262 Added 40.49%	35,605 $2.75 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $62,683 - $79,944	-874 Reduced 3.33%	25,343 $2.24 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $1.96 Million - $2.24 Million	26,217 New	26,217 $2.03 Million
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $4,035 - $4,897	-54 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$72.61 - $90.2 $9,802 - $12,177	-135 Reduced 71.43%	54 $5,000
Q3 2020 Nov 06, 2020	BUY	$71.87 - $131.03 $503 - $917	7 Added 3.85%	189 $14,000
Q2 2020 Jul 15, 2020	BUY	$79.55 - $124.22 $9,307 - $14,533	117 Added 180.0%	182 $22,000
Q2 2019 Aug 12, 2019	SELL	$80.35 - $93.9 $160 - $187	-2 Reduced 2.99%	65 $6,000
Q1 2019 Apr 29, 2019	BUY	$84.2 - $98.62 $757 - $887	9 Added 15.52%	67 $6,000
Q4 2018 Feb 04, 2019	SELL	$80.14 - $106.07 $12,341 - $16,334	-154 Reduced 72.64%	58 $5,000
Q3 2018 Nov 07, 2018	BUY	$93.92 - $105.72 $11,270 - $12,686	120 Added 130.43%	212 $21,000
Q2 2018 Jul 31, 2018	SELL	$76.01 - $99.03 $11,781 - $15,349	-155 Reduced 62.75%	92 $9,000
Q1 2018 May 14, 2018	BUY	$77.67 - $92.63 $11,572 - $13,801	149 Added 152.04%	247 $20,000
Q3 2017 Oct 18, 2017	BUY	$80.6 - $94.95 $7,898 - $9,305	98	98 $9,000

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

184M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account